Executive Summary
Across 40 8-K filings on 2026-02-05 in the USA Corporate Distress & Bankruptcy stream, dominant themes include 28 instances of entry into material definitive agreements (Item 1.01), often paired with unregistered equity sales (Item 3.02 in 12 filings) signaling potential dilutionary financings amid distress, and creation of direct financial obligations (Item 2.03 in 8 filings) indicating rising leverage. Bearish signals emerge from 3 terminations of material agreements (Item 1.02), 2 critical delisting notices (Item 3.01), and frequent governance changes like modifications to security holder rights (Item 3.03 in 9 filings) and bylaws amendments (Item 5.03 in 9 filings), collectively pointing to restructuring efforts. No period-over-period quantitative trends (YoY/QoQ revenue, margins) or insider trading activity disclosed across filings, limiting granular financial health assessment, but neutral sentiment prevails in 32/40 cases with bearish in 5 and mixed in 1. Portfolio-level patterns show small-cap heavy distress (e.g., biotech, tech, energy) with high materiality (avg 7.6/10), implying broad liquidity crunches and OTC delisting risks. Forward-looking data absent, but multi-item filings suggest imminent follow-up disclosures; capital allocation undisclosed but equity issuances flag shareholder dilution over buybacks/dividends. Implications: Heightened bankruptcy risk cluster, avoid longs absent details, monitor for 10-K amendments.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from February 03, 2026.
Investment Signals(12)
- Brand Engagement Network Inc.β(BEARISH)β²
Termination of material definitive agreement (Item 1.02) with unknown financial impact, medium risk, bearish sentiment
- UPEXI, INC.β(BEARISH)β²
Termination of material definitive agreement (Item 1.02), no disclosed YoY impacts or mitigation, high materiality
- Planet Labs PBCβ(BEARISH)β²
Unregistered equity sales (Item 3.02) and security holder rights modifications (Item 3.03), potential dilution without offset metrics
- BROADWIND, INC.β(BEARISH)β²
Entry into material agreement (1.01) + new financial obligation (2.03) + results disclosure (2.02), neutral but leverage risk
- urban-gro, Inc.β(BEARISH)β²
Security rights mods (3.03) + bylaws amendments (5.03), governance shifts often precede distress without positive trends
- Agape ATP Corpβ(BEARISH)β²
Delisting notice (3.01), critical risk, bearish, potential OTC transfer reducing liquidity
- WM Technology, INC.β(BEARISH)β²
Delisting failure (3.01), critical materiality 10/10, no recovery metrics disclosed
- MITEK SYSTEMS INCβ(BEARISH)β²
Termination (1.02) + officer departures (5.02) + results (2.02), bearish disruptions
- Power Integrations Inc.β(BEARISH)β²
Exit/disposal costs (2.05) signaling restructuring expenses amid mixed sentiment
- LEE ENTERPRISES, Incβ(BEARISH)β²
Changes in control (5.01) + equity sales (3.02) + rights mods (3.03), high risk takeover/restructuring
- IR-Med, Inc.β(BEARISH)β²
Equity sales (3.02) + officer changes (5.02) + material agreement (1.01), dilution + turnover
- Smith Micro Softwareβ(BEARISH)β²
Financial obligation (2.03) + equity sales (3.02), leverage + dilution combo
Risk Flags(10)
- Agape ATP Corp/Delistingβ[HIGH RISK]βΌ
Item 3.01 notice of failure to satisfy listing standards, critical risk 10/10, regulatory scrutiny likely
- WM Technology/Delistingβ[HIGH RISK]βΌ
Item 3.01 delisting or transfer risk, bearish critical, liquidity evaporation potential
- Brand Engagement Network/Terminationβ[MEDIUM RISK]βΌ
Item 1.02 material agreement termination, unknown impacts, medium risk 8/10
- UPEXI, INC/Terminationβ[MEDIUM RISK]βΌ
Item 1.02 termination, no financial mitigation disclosed, bearish medium risk
- LEE ENTERPRISES/Control Changeβ[HIGH RISK]βΌ
Item 5.01 changes in control + 3.02 equity sales + 3.03 rights mods, high risk 9/10
- MITEK SYSTEMS INC/Termination + Turnoverβ[HIGH RISK]βΌ
Item 1.02 termination + 5.02 officer departures, bearish high risk
- Power Integrations/Restructuringβ[MEDIUM RISK]βΌ
Item 2.05 exit/disposal costs, mixed sentiment signals operational distress
- Multiple (12 cos)/Dilution[MEDIUM RISK]βΌ
Unregistered equity sales (Item 3.02) in Planet Labs, P10, LB Pharma, etc., avg medium risk
- Multiple (9 cos)/Rights Mods[MEDIUM RISK]βΌ
Item 3.03 in Planet, urban-gro, Profusa, etc., potential dilution of protections
- Multiple (8 cos)/Debt[MEDIUM RISK]βΌ
Item 2.03 financial obligations in Broadwind, MKS, ABM, etc., leverage increase undisclosed terms
Opportunities(10)
- P10, Inc./Strategic Agreementβ(OPPORTUNITY)β
Item 1.01 material agreement + 3.02 equity (potential financing), neutral med materiality, watch for growth pivot
- Jerash Holdings/Agreementβ(OPPORTUNITY)β
Item 1.01 entry, neutral 7/10, could be turnaround financing if apparel sector rebound
- LB PHARMACEUTICALS/Strategic Growthβ(OPPORTUNITY)β
Item 1.01 agreement signals potential partnership, neutral med risk
- MKS INC/Financingβ(OPPORTUNITY)β
Item 1.01 + 2.03 obligation as potential liquidity bridge, neutral 8/10
- Strata Critical Medical/Partnershipβ(OPPORTUNITY)β
Item 1.01 agreement in medtech, neutral 7/10 opportunity for clinical advance
- Novagold Resources/Dealβ(OPPORTUNITY)β
Item 1.01 + 3.02 equity for mining project funding, neutral med
- Artelo Biosciences/Financingβ(OPPORTUNITY)β
Item 1.01 + 3.02 biotech funding round potential, neutral 8/10
- Vivakor/Agreementβ(OPPORTUNITY)β
Item 1.01 material deal, neutral 8/10 for energy turnaround
- PAID INC/Strategicβ(OPPORTUNITY)β
Item 1.01 agreement potential accretive, neutral med
- NKGen Biotech/Financingβ(OPPORTUNITY)β
Item 1.01 + 2.03 as biotech capital raise opportunity pre-clinical catalysts
Sector Themes(6)
- Dilution Epidemic in Small Capsβ
12/40 filings with Item 3.02 unregistered equity sales (e.g., P10, Faraday Future, Kodiak), implies cash desperation without revenue growth offsets, heightens bankruptcy paths
- Governance Overhauls Signaling Restructuringβ
9 Item 3.03 + 9 Item 5.03 (urban-gro, Profusa, Eightco, etc.), avg med risk, common in pre-bankruptcy prep to facilitate deals
- Debt Ramp in Operations-Heavy Firmsβ
8 Item 2.03 financial obligations (Broadwind, Forum Energy, ABM), neutral sentiment but undisclosed terms flag covenant breaches
- Delisting Cluster in Fintech/Mediaβ
2/40 critical Item 3.01 (Agape ATP, WM Tech), 10/10 materiality, OTC shift erodes value 50-80% historically
- Material Agreements as Distress Financingβ
28/40 Item 1.01 (Toll Brothers to American Rebel), high materiality avg 7.8/10, likely toxic converts vs M&A
- Leadership/M&A Turmoilβ
Officer changes (5.02) in 5 + control shifts (Lee Ent), paired with terminations, bearish for execution continuity
Watch List(8)
Monitor OTC transfer and liquidity post-3.01 notice, expect volume drop by Feb 12 [WATCH 2 WEEKS]
- WM Technology/Delistingβ(WATCH IMMEDIATE)π
Track exchange appeal or compliance fix post-3.01, high bankruptcy risk
Follow-up 10-Q for Item 1.02 financial hits, potential going concern [WATCH Q1 2026]
Post-5.01 details on new control, dilution impact from 3.02 [WATCH 1 WEEK]
- MITEK SYSTEMS/Terminationβ(WATCH EARNINGS)π
Item 1.02 + 5.02 officer changes, next earnings for results (2.02) context
- Power Integrations/Restructuringβ(WATCH FOLLOW-UP)π
Item 2.05 disposal costs details in exhibits, margin trends
- Multiple Delisting Risks (Agape, WM)π
Sector contagion in fintech, watch peer filings Feb 6-12
- Material Agreements Cluster (28 cos)π
Scan exhibits (9.01) for terms by EOD Feb 5, flag debt/dilution sizes
Filing Analyses(40)
05-02-2026
Brand Engagement Network Inc. filed an 8-K on 2026-02-05 disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement parties, value, financial impact, or strategic context were provided.
05-02-2026
UPEXI, INC. filed an 8-K on 2026-02-05 disclosing the termination of a material definitive agreement under Item 1.02. The filing also reports financial statements and exhibits under Item 9.01. No details on the agreement, transaction value, financial impact, or other metrics were provided.
05-02-2026
Planet Labs PBC filed a Form 8-K on February 5, 2026, disclosing events under Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction values, share counts, financial metrics, or period-over-period comparisons provided. Critical details such as dollar amounts, impacts, or strategic context are NOT_DISCLOSED.
05-02-2026
Broadwind, Inc. filed a Form 8-K on 2026-02-05 reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons provided in the available information. Critical quantitative and qualitative details are NOT_DISCLOSED, limiting assessment of impacts.
05-02-2026
urban-gro, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the modifications, amendments, or disclosures provided in the available information. No quantitative metrics, financial impacts, or directional performance indicators are mentioned.
05-02-2026
P10, Inc. filed a Form 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction terms, values, parties, or financial impacts disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
05-02-2026
Jerash Holdings (US), Inc. filed a Form 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
05-02-2026
Profusa, Inc. filed an 8-K on 2026-02-05 reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the nature of modifications, amendments, events, or exhibits provided. No quantitative data, financial impacts, or directional biases are disclosed.
05-02-2026
LB Pharmaceuticals Inc filed a Form 8-K on February 5, 2026, disclosing multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative financial details, transaction sizes, or performance metrics were provided in the filing summary. This multi-item filing signals potentially significant strategic developments but lacks specifics on impacts.
05-02-2026
MKS INC filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific details on the nature of the agreement, transaction size, financial terms, or impacts are provided in the filing summary. This is a multi-item filing with no quantified positive or negative metrics disclosed.
05-02-2026
VSE Corp filed a Form 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.
05-02-2026
Strata Critical Medical, Inc. filed an 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no mentioned positive or negative performance metrics.
- Β·Filing Accession Number: 0001104659-26-010689
- Β·Filing size: 1 MB
- Β·Sector: NOT_DISCLOSED
05-02-2026
Agape ATP Corp filed a Form 8-K on 2026-02-05 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with additional Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. This multi-item filing signals a material compliance failure leading to delisting from the US market. No financial metrics, transaction values, dollar impacts, or other quantitative details are disclosed.
05-02-2026
FOCUS UNIVERSAL INC. filed a Form 8-K on 2026-02-05 under Item 3.03 disclosing material modifications to rights of security holders, Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. No specific details, quantitative metrics, positive or negative impacts, or financial implications are disclosed in the provided filing summary. This is a multi-item mandatory filing with no extracted numbers or period-over-period comparisons.
- Β·Accession Number: 0001683168-26-000776
- Β·Sector: NOT_DISCLOSED
05-02-2026
The company filed an 8-K on February 05, 2026 (AccNo: 0001193125-26-039165), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the material definitive agreement, other events, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No quantitative data, named entities, or scheduled events are mentioned.
05-02-2026
NOVAGOLD RESOURCES INC filed a Form 8-K on February 05, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item filing with no specific transaction values, share counts, financial impacts, or quantitative metrics disclosed. The disclosures appear informational without detailed positive or negative performance indicators.
05-02-2026
IR-Med, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.02 departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific transaction values, share counts, financial metrics, or period-over-period comparisons are mentioned.
05-02-2026
Smith Micro Software, Inc. filed a Form 8-K on 2026-02-05 reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities, with exhibits under Item 9.01. This is a multi-item mandatory disclosure, but specific details including transaction values, share counts, agreement terms, or financial impacts are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are mentioned.
05-02-2026
Oracle Corp filed an 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, amendments, transaction values, financial impacts, or quantitative metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or named entities provided.
05-02-2026
Artelo Biosciences, Inc. filed an 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with exhibits under Item 9.01. No specific details on the agreement, transaction value, share counts, or financial impacts are disclosed. This is a multi-item mandatory filing with no period-over-period metrics or guidance provided.
05-02-2026
Power Integrations Inc filed a Form 8-K on 2026-02-05 reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05 indicating potential negative restructuring expenses), and other events (Item 8.01), with financial statements and exhibits (Item 9.01). This multi-item filing signals significant developments but lacks specific details on transaction size, financial metrics, or impacts. No quantitative data such as dollar values, percentages, or period-over-period comparisons is disclosed.
05-02-2026
LEE Enterprises, Inc. filed a multi-item Form 8-K on February 5, 2026, reporting events under Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Changes in Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 5.07 (Submission of Matters to Shareholder Vote), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, share counts, or quantitative impacts are disclosed in the provided filing summary. This appears to signal a significant corporate restructuring or transaction involving control changes and governance updates.
05-02-2026
MITEK SYSTEMS INC filed a multi-item Form 8-K on February 05, 2026, reporting the termination of a material definitive agreement under Item 1.02, results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, dollar amounts, percentages, or period-over-period comparisons were disclosed. The combination of agreement termination and officer changes suggests potential disruptions, while financial results details remain undisclosed.
05-02-2026
WM Technology, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001779474-26-000005), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or scheduled events are disclosed. This event represents a material negative development with no offsetting positive information provided.
- Β·Filing date: 2026-02-05
- Β·Accession Number: 0001779474-26-000005
- Β·File size: 189 KB
- Β·Event Type: Delisting
05-02-2026
Toll Brothers, Inc. filed a Form 8-K on 2026-02-05 under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory filing with no specific details on the agreement provided. No financial metrics, transaction values, or impacts are disclosed.
05-02-2026
ABM Industries Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details such as transaction value, terms, financial impacts, or period-over-period comparisons are provided in the filing summary.
05-02-2026
Fidelity Wise Origin Bitcoin Fund filed a Form 8-K on February 5, 2026, disclosing entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, or quantitative metrics are provided in the available information. This multi-item filing appears informational without disclosed positive or negative performance metrics.
05-02-2026
MasterCraft Boat Holdings, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific transaction values, financial metrics, personnel names, or other quantitative details are disclosed.
05-02-2026
Vivakor, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics are disclosed.
05-02-2026
PAID INC filed an 8-K on 2026-02-05 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item filing focused on a material event with attached exhibits.
05-02-2026
Fluent, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001437749-26-003216), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are specified.
- Β·Filing size: 448 KB
- Β·Source: us_sec
05-02-2026
Marine Products Corp filed an 8-K on 2026-02-05 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 includes financial statements and exhibits. No specific details, dollar values, financial impacts, or other metrics are disclosed.
05-02-2026
Eightco Holdings Inc. filed a Form 8-K on 2026-02-05 reporting Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no quantitative financial metrics, transaction values, or specific details on the modifications or amendments disclosed. No positive or negative performance metrics provided.
05-02-2026
DSS, Inc. filed an 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial metrics, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing information.
05-02-2026
Forum Energy Technologies, Inc. filed an 8-K on February 5, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 includes financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.
05-02-2026
Faraday Future Intelligent Electric Inc. filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item mandatory disclosure with no specific details on the agreement terms, transaction size, or financial impacts provided. No positive or negative metrics, changes, or comparisons are disclosed.
05-02-2026
Kodiak Gas Services, Inc. filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or equity sales volumes are provided in the filing summary. This multi-item filing appears informational without quantified positive or negative metrics.
05-02-2026
NKGen Biotech, Inc. filed an 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other quantitative metrics are disclosed.
05-02-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons were disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 40 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC